Alendronic Acid Jelly 70MG - LEFOS jelly Sachet

LEFOS Jelly Sachet – Convenient Weekly Solution for Stronger Bones.

LEFOS Jelly Sachet – Alendronic Acid Jelly 70 mg, a bisphosphonate, works by targeting and binding to mineralized bone surfaces, especially in regions with active bone resorption. Once absorbed by osteoclasts—the cells responsible for breaking down bone—it inhibits their activity, thereby reducing bone breakdown and preserving bone density and strength. It is also effective in treating Paget’s disease, a disorder marked by abnormal bone remodeling, by helping restore a healthy balance between bone formation and resorption. The jelly formulation is designed to enhance patient compliance, particularly for individuals with swallowing difficulties or gastrointestinal sensitivities.

Key Benefits of Alendronic Acid Jelly 70 mg – LEFOS Jelly Sachet:
✅ Easy-to-use Jelly Form – Enhances ease of administration and compliance, especially for patients with difficulty swallowing traditional tablets.
✅ Supports Osteoporosis Management – Inhibits bone resorption, increasing bone density and reducing fracture risk.
✅ Weekly Dosing Convenience – Simplifies treatment regimen, ensuring better adherence for long-term bone health.

Recommended by Specialists:
👨‍⚕️ Orthopedists – for managing osteoporosis, fractures, and bone health.
👨‍⚕️ Rheumatologists – for osteoporosis associated with autoimmune or inflammatory conditions.
👨‍⚕️ Geriatricians – for age-related bone density loss in older adults.

Indications:
✅ Osteoporosis in postmenopausal women
✅ Osteoporosis in men
✅ Prevention of glucocorticoid-induced osteoporosis
✅ Paget’s disease of bone